$28.24
0.46% today
NYSE, Apr 01, 07:14 pm CET
ISIN
US83175M2052
Symbol
SNN
Sector

Smith & Nephew PLC Sponsored ADR Stock price

$28.37
-0.59 2.04% 1M
-2.77 8.90% 6M
+3.79 15.42% YTD
+3.83 15.61% 1Y
-3.53 11.07% 3Y
-7.50 20.91% 5Y
-5.80 16.97% 10Y
NYSE, Closing price Mon, Mar 31 2025
+0.32 1.14%
ISIN
US83175M2052
Symbol
SNN
Sector

Key metrics

Market capitalization $12.39b
Enterprise Value $15.09b
P/E (TTM) P/E ratio 30.19
EV/FCF (TTM) EV/FCF 25.16
EV/Sales (TTM) EV/Sales 2.61
P/S ratio (TTM) P/S ratio 2.14
P/B ratio (TTM) P/B ratio 2.35
Dividend yield 2.64%
Last dividend (FY24) $0.75
Revenue growth (TTM) Revenue growth 4.58%
Revenue (TTM) Revenue $5.78b
EBIT (operating result TTM) EBIT $857.19m
Free Cash Flow (TTM) Free Cash Flow $599.90m
EPS (TTM) EPS $0.94
P/E forward 19.89
P/S forward 2.04
EV/Sales forward 2.49
Short interest 0.26%
Show more

Is Smith & Nephew PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Smith & Nephew PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Smith & Nephew PLC Sponsored ADR forecast:

8x Buy
44%
10x Hold
56%

Analyst Opinions

18 Analysts have issued a Smith & Nephew PLC Sponsored ADR forecast:

Buy
44%
Hold
56%

Financial data from Smith & Nephew PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
5,780 5,780
5% 5%
100%
- Direct Costs 1,755 1,755
2% 2%
30%
4,025 4,025
6% 6%
70%
- Selling and Administrative Expenses 2,239 2,239
10% 10%
39%
- Research and Development Expense 287 287
15% 15%
5%
1,498 1,498
4% 4%
26%
- Depreciation and Amortization 641 641
6% 6%
11%
EBIT (Operating Income) EBIT 857 857
13% 13%
15%
Net Profit 410 410
56% 56%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Smith & Nephew PLC Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Smith & Nephew PLC Sponsored ADR Stock News

Negative
Proactive Investors
20 days ago
Shares in Smith & Nephew PLC (LSE:SN) fell 2% after UBS downgraded stock in the med-tech firm to 'neutral' from 'buy' on valuation grounds. The price target remains at £12.50.
Neutral
GlobeNewsWire
21 days ago
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:
Neutral
GlobeNewsWire
22 days ago
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:
More Smith & Nephew PLC Sponsored ADR News

Company Profile

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Deepak Nath
Employees 18,456
Founded 1856
Website www.smith-nephew.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today